Wilfred F.J. Van IJcken received his PhD in Molecular Sciences from the Wageningen University and Research Center, The Netherlands in 2001. During his PhD, he sequenced and annotated the SeMNPV virus genome, resulting in the identification of a novel structural virus protein and a novel baculovirus envelope fusion protein. In 2002, he joined as a post-doc the group of Prof. Frank Grosveld at Erasmus MC in Rotterdam, where he initiated and started the genomics core facility. He implemented a wide range of genomics techniques including microarrays, imaging, and high throughput automation. In 2007, he was one of the first to offer next-generation sequencing to the Dutch research community. He was appointed as assistant professor in 2008 to boost innovation in next-generation sequencing technology. Implementation of next-generation sequencing in clinical diagnostics was achieved in 2012 and further professionalized by achieving ISO15189 accreditation in 2016. He is the co-founder of the startup company Methylomics, focusing on methylation sequencing. Currently, he is responsible for the daily management (both financial and operational) of the genomics core facility. He is also actively involved in medical student teaching and training. He is participating in several national programs and is an organizer of many NGS data analysis courses.